Viridian Therapeutics Inc (VRDN)
Healthcare
Biotechnology
19.30 $
+2.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Viridian Therapeutics Inc (VRDN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -120 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -45 | -39 | -38 | -45 | -46 | -68 | -73 | -93 | -75 | -85 | -24 | -120 | -303 | |
| 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | -13 | 0.1 | 0.1 | 0.1 | 0.1 | -0.9 | 0.1 | -0.5 | |
| 12 | 14 | 26 | 13 | 12 | 8.7 | 9.0 | 10 | 11 | 11 | 12 | 13 | 47 | |
| 17 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.7 | -4.1 | 5.6 | -5.0 | 11 | -6.2 | 0.5 | -14 | 16 | -60 | 81 | -21 | 15 | |
| 0.3 | 0.4 | 0.0 | 0.0 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 | 0.2 | 0.0 | 0.4 | |
| 41 | 48 | -170 | -143 | 62 | -85 | -63 | 100 | 76 | 126 | -339 | 77 | -60 | |
| 3.1 | – | 0.3 | 0.4 | – | 0.3 | – | – | 0.6 | 1.1 | -1.1 | – | – | |
| – | – | – | – | – | – | 0.0 | – | – | – | – | – | – | |
| 3.1 | 15 | 199 | 177 | 0.1 | 245 | 36 | 9.2 | 0.8 | 11 | 406 | 6.4 | 424 | |
| -1.4 | 25 | -8.8 | -11 | 16 | 93 | -101 | 17 | 1.1 | 52 | 43 | -36 | 60 | |
| -46 | -39 | -38 | -45 | -46 | -68 | -73 | -93 | -75 | -85 | -24 | -120 | -304 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.